Data extracted from the reviewed literature focused on the type of PD-1/PD-L1 inhibitors administered, underlying malignancy, use of adjuvant therapy in the metastatic setting, patient demographics including age and sex, time to HLH onset, HLH identification, treatment approaches, clinical outcomes and mortality, and author recommendations. Here, CD274 is linked to hemophagocytic syndrome.